Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection

被引:87
作者
Li, Yi-Wei
Qiu, Shuang-Jian
Fan, Jia [1 ]
Gao, Qiang
Zhou, Jian
Xiao, Yong-Sheng
Xu, Yang
Wang, Xiao-Ying
Sun, Jian
Huang, Xiao-Wu
机构
[1] Fudan Univ, Zhong Shan Hosp, Shanghai Med Sch, Liver Canc Inst, Shanghai 200032, Peoples R China
基金
芬兰科学院; 中国国家自然科学基金;
关键词
Tumor-associated macrophages (TAM); CD45RO+T cell (T-M); Hepatocellular carcinoma (HCC); Prognosis; VEGF EXPRESSION; NECROSIS-FACTOR; NITRIC-OXIDE; T-CELLS; CANCER; LIVER; SURVIVAL; ANGIOGENESIS; PROGRESSION; RECURRENCE;
D O I
10.1007/s00432-008-0469-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
To evaluate the prognostic value of tumor-associated macrophages (TAM), individually or synergistically with CD45RO + memory T cells (T-M), in hepatocellular carcinoma (HCC) patients following resection. The infiltration of TAM and T-M was assessed by immunohistochemistry in tissue microarray containing 302 HCC specimens. Correlations between TAM/T-M infiltration and clinicopathologic features, disease-free survival (DFS) and overall survival (OS) were statistically analyzed. High TAM infiltration was associated with both improved DFS (P = 0.0021) and OS (P = 0.0481). Multivariate analysis identified TAM infiltration as independent prognostic factor for DFS (P = 0.004) and OS (P = 0.049). A second analysis clarified the synergistic effect of TAM&T-M infiltration for DFS (P = 0.004) and OS (P = 0.040). Both TAM infiltration alone and concomitant infiltration of TAM&T-M are associated with improved DFS/OS, suggesting that TAM could protect HCC patients from recurrence/metastasis and prolong survival by distinct mechanisms.
引用
收藏
页码:439 / 449
页数:11
相关论文
共 41 条
[1]
Abe K, 1998, CANCER IMMUNOL IMMUN, V45, P225
[2]
TUMOR SUPPRESSION AFTER TUMOR-CELL TARGETED TUMOR-NECROSIS-FACTOR-ALPHA GENE-TRANSFER [J].
BLANKENSTEIN, T ;
QIN, ZH ;
UBERLA, K ;
MULLER, W ;
ROSEN, H ;
VOLK, HD ;
DIAMANTSTEIN, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1047-1052
[3]
Bolat F, 2006, J EXP CLIN CANC RES, V25, P365
[4]
INVOLVEMENT OF INFLAMMATORY MEDIATORS IN MACROPHAGE ANTITUMOR-ACTIVITY [J].
BONTA, IL ;
BENEFRAIM, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 54 (06) :613-626
[5]
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer [J].
Bortolami, M ;
Venturi, C ;
Giacomelli, L ;
Scalerta, R ;
Bacchetti, S ;
Marino, F ;
Floreani, A ;
Lise, M ;
Naccarato, R ;
Farinati, F .
DIGESTIVE AND LIVER DISEASE, 2002, 34 (11) :794-801
[6]
Tumors and inflammatory infiltrates: Friends or foes? [J].
Brigati, C ;
Noonan, DM ;
Albini, A ;
Benelli, R .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (03) :247-258
[7]
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment [J].
Budhu, Anuradha ;
Forgues, Marshonna ;
Ye, Qing-Hai ;
Jia, Hu-Liong ;
He, Ping ;
Zanetti, Krista A. ;
Kammula, Udai S. ;
Chen, Yidong ;
Qin, Lun-Xiu ;
Tang, Zhao-You ;
Wang, Xin Wei .
CANCER CELL, 2006, 10 (02) :99-111
[8]
Dendritic cell infiltration and prognosis of human hepatocellular carcinoma [J].
Cai, XY ;
Gao, Q ;
Qiu, SJ ;
Ye, SL ;
Wu, ZQ ;
Fan, J ;
Tang, ZY .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (05) :293-301
[9]
Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patients [J].
Chu, CS ;
Woo, EY ;
Toll, AJ ;
Rubin, SC ;
June, CH ;
Carroll, RG ;
Schlienger, K .
CLINICAL IMMUNOLOGY, 2002, 102 (03) :291-301
[10]
Paradoxical roles of the immune system during cancer development [J].
de Visser, KE ;
Eichten, A ;
Coussens, LM .
NATURE REVIEWS CANCER, 2006, 6 (01) :24-37